Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Nan-Ya Wang"'
Autor:
Chao-Xu Yang, Yang-Xun Pan, Feng Ye, Xiao-Dong Zhu, Jun Xue, Xi Li, Zhen-Gang Yuan, Lan Zhang, Li Xu, Yong-Jun Chen, Nan-Ya Wang, Hui-Chuan Sun, Xiu-Feng Liu, China Liver Cancer Study Group Young Investigators (CLEAP)
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundFor decades, stratification criteria for first-line clinical studies have been highly uniform. However, there is no principle or consensus for restratification after systemic treatment progression based on immune checkpoint inhibitors (ICIs
Externí odkaz:
https://doaj.org/article/3356a8d222e74518a0137217ece0f0dc
Autor:
Jia-Xin Huang, Bo Liu, Xiao-Feng Cong, Yan-Jie Guan, Yi-Qun Zhang, Wei Song, Zhi Li, Zi-Ling Liu, Nan-Ya Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has resulted in infections among patients with cancer. Our study aimed to investigate the potential adverse impact of anti-cancer treatments within 2 weeks of COVID-19 infection on clinical o
Externí odkaz:
https://doaj.org/article/cbac735b82f14e109a45f12239fd1096
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIntrahepatic cholangiocarcinoma (ICC) is a highly aggressive primary liver cancer, with increasing incidence worldwide. Effective first-line treatments for advanced ICC patients are currently limited. Therefore, our study aimed to assess th
Externí odkaz:
https://doaj.org/article/9d880d6d2a844c84a011cbff746de81d
Autor:
Gang Hou, Bo Liu, Zhong-Qi Fan, Chao Li, Jian-Ping Zhang, Yan-Hui Guo, Ru-Yi Zhang, Yi Zheng, Hong Zhu, Nan-Ya Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundAlpha-fetoprotein (AFP) is a well-identified biomarker in hepatocellular carcinoma (HCC). However, only limited AFP-related studies have evaluated its early response to systemic therapy. This study was performed with the aim of assessing th
Externí odkaz:
https://doaj.org/article/9f4c0316518640acb51cd89f61a273d1
Autor:
Ming-Da Wang, Nan-Ya Wang, Hui-Lu Zhang, Li-Yang Sun, Qiu-Ran Xu, Lei Liang, Chao Li, Dong-Sheng Huang, Hong Zhu, Tian Yang
Publikováno v:
Oncogenesis, Vol 10, Iss 11, Pp 1-11 (2021)
Abstract Aberrant lipid metabolism is an essential feature of hepatocellular carcinoma (HCC). Fatty acid transport protein-5 (FATP5) is highly expressed in the liver and is involved in the fatty acid transport pathway. However, the potential role of
Externí odkaz:
https://doaj.org/article/c58f452b6290429e9c3ff179844f4f53
Autor:
Lei Liang, Chao Li, Ming-Da Wang, Hong Wang, Ya-Hao Zhou, Yong-Yi Zeng, Wan-Guang Zhang, Ting-Hao Chen, Nan-Ya Wang, Jie Li, Yao-Ming Zhang, Yu Wang, Wei-Min Gu, Hao Xing, Yong-Kang Diao, Wan Yee Lau, Cheng-Wu Zhang, Timothy M. Pawlik, Feng Shen, Dong-Sheng Huang, Tian Yang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-6 (2021)
Abstract Background and aims Although adjuvant transcatheter arterial chemoembolization (TACE) for resected hepatocellular carcinoma (HCC) may improve survival for some patients, identifying which patients can benefit remains challenging. The present
Externí odkaz:
https://doaj.org/article/d7d1ca1eceb04c829d6f65e0091460b3
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background/PurposeLenvatinib is a first-line treatment for unresectable hepatocellular carcinoma (uHCC). We assessed the value of early alpha-fetoprotein (AFP) response for predicting clinical outcomes with lenvatinib treatment in patients with HBV-r
Externí odkaz:
https://doaj.org/article/57cb9c7da77a4c2fbae98d5719335dd3
Publikováno v:
Frontiers in Oncology; 2023, p1-12, 12p
Autor:
Lei Liang, Hong Zhu, Qiu-Ran Xu, Tian Yang, Li-Yang Sun, Ming-Da Wang, Nan-Ya Wang, Chao Li, Dong-Sheng Huang, Hui-Lu Zhang
Publikováno v:
Oncogenesis, Vol 10, Iss 11, Pp 1-11 (2021)
Oncogenesis
Oncogenesis
Aberrant lipid metabolism is an essential feature of hepatocellular carcinoma (HCC). Fatty acid transport protein-5 (FATP5) is highly expressed in the liver and is involved in the fatty acid transport pathway. However, the potential role of FATP5 in
Publikováno v:
journal of nutritional oncology. 5:147-152